Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Parkinson's Disease

  Free Subscription


2 Ann Neurol
1 Exp Neurol
1 J Neural Transm (Vienna)
1 J Neurol Neurosurg Psychiatry
1 J Neuropsychol
5 Mov Disord
1 Nature
1 Neurobiol Dis
1 Neurology
3 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Neurol

  1. STORZER L, Butz M, Hirschmann J, Abbasi O, et al
    Bicycling suppresses abnormal beta synchrony in the Parkinsonian basal ganglia.
    Ann Neurol. 2017 Sep 11. doi: 10.1002/ana.25047.
    PubMed     Text format     Abstract available

  2. STRANIERO L, Guella I, Cilia R, Parkkinen L, et al
    DNAJC12 and dopa-responsive non-progressive Parkinsonism.
    Ann Neurol. 2017 Sep 11. doi: 10.1002/ana.25048.
    PubMed     Text format     Abstract available

    Exp Neurol

  3. KUHN J, Haumesser JK, Beck MH, Altschuler J, et al
    Differential effects of levodopa and apomorphine on neuronal population oscillations in the cortico-basal ganglia loop circuit in vivo in experimental parkinsonism.
    Exp Neurol. 2017 Sep 8. pii: S0014-4886(17)30235.
    PubMed     Text format     Abstract available

    J Neural Transm (Vienna)

  4. SATO S, Li Y, Hattori N
    Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.
    J Neural Transm (Vienna). 2017 Sep 11. doi: 10.1007/s00702-017-1779.
    PubMed     Text format     Abstract available

    J Neurol Neurosurg Psychiatry

  5. JOLING M, van den Heuvel OA, Berendse HW, Booij J, et al
    Serotonin transporter binding and anxiety symptoms in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Sep 12. pii: jnnp-2017-316193.
    PubMed     Text format     Abstract available

    J Neuropsychol

  6. BEK J, Gowen E, Vogt S, Crawford T, et al
    Action observation produces motor resonance in Parkinson's disease.
    J Neuropsychol. 2017 Sep 11. doi: 10.1111/jnp.12133.
    PubMed     Text format     Abstract available

    Mov Disord

  7. Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative
    Mov Disord. 2017;32:e1-e19.
    PubMed     Text format    

  8. OBESO JA, Stamelou M, Goetz CG, Poewe W, et al
    Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
    Mov Disord. 2017;32:1264-1310.
    PubMed     Text format     Abstract available

  9. FRISALDI E, Carlino E, Zibetti M, Barbiani D, et al
    The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning.
    Mov Disord. 2017 Sep 12. doi: 10.1002/mds.27142.
    PubMed     Text format     Abstract available

  10. SAME K, Ghazi Sherbaf F, Aarabi MH
    New link between Parkinson's and Alzheimer's: Research uncovers the role of mutant leucine rich repeat kinase 2 and amyloid precursor protein.
    Mov Disord. 2017 Sep 13. doi: 10.1002/mds.27170.
    PubMed     Text format    

  11. FULLARD ME, Xie SX, Marek K, Stern M, et al
    Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study.
    Mov Disord. 2017 Sep 14. doi: 10.1002/mds.27127.
    PubMed     Text format     Abstract available


  12. SULZER D, Alcalay RN, Garretti F, Cote L, et al
    Erratum: T cells from patients with Parkinson's disease recognize alpha-synuclein peptides.
    Nature. 2017;549:292.
    PubMed     Text format     Abstract available

    Neurobiol Dis

  13. SYRKIN-NIKOLAU J, Koop MM, Prieto T, Anidi C, et al
    Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's disease.
    Neurobiol Dis. 2017 Sep 7. pii: S0969-9961(17)30214.
    PubMed     Text format     Abstract available


  14. LECLAIR-VISONNEAU L, Clairembault T, Coron E, Le Dily S, et al
    REM sleep behavior disorder is related to enteric neuropathology in Parkinson disease.
    Neurology. 2017 Sep 8. pii: 10.1212/WNL.0000000000004496.
    PubMed     Text format     Abstract available

    PLoS One

  15. SIMIELI L, Gobbi LTB, Orcioli-Silva D, Beretta VS, et al
    The variability of the steps preceding obstacle avoidance (approach phase) is dependent on the height of the obstacle in people with Parkinson's disease.
    PLoS One. 2017;12:e0184134.
    PubMed     Text format     Abstract available

  16. ZHU H, Lemos H, Bhatt B, Islam BN, et al
    Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity.
    PLoS One. 2017;12:e0183484.
    PubMed     Text format     Abstract available

  17. TUGAEVA KV, Tsvetkov PO, Sluchanko NN
    Bacterial co-expression of human Tau protein with protein kinase A and 14-3-3 for studies of 14-3-3/phospho-Tau interaction.
    PLoS One. 2017;12:e0178933.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

  18. THAKUR P, Breger LS, Lundblad M, Wan OW, et al
    Modeling Parkinson's disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain.
    Proc Natl Acad Sci U S A. 2017 Sep 12. pii: 201710442.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.